Glycomimetics Inc. Stock
Price
Target price
€1.83
€1.83
6.770%
0.116
6.770%
€7.35
13:01 / Tradegate
WKN: A1W8HZ / Symbol: GLYC / Name: GlycoMimetics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Glycomimetics Inc. Stock
Glycomimetics Inc. dominated the market today, gaining €0.12 (6.770%).
Currently there is a rather positive sentiment for Glycomimetics Inc. with 5 Buy predictions and 0 Sell predictions.
Based on the current price of 1.83 € the target price of 7 € shows a potential of 282.51% for Glycomimetics Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Glycomimetics Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Glycomimetics Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Glycomimetics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Glycomimetics Inc. | 6.770% | -15.567% | -37.101% | 30.243% | -24.159% | -18.381% | - |
| Ardelyx Inc. | 2.280% | -5.482% | -15.972% | 32.578% | 3.218% | -12.905% | - |
| Salarius Pharmaceuticals Inc. | 4.250% | -0.935% | -18.462% | -68.120% | -23.604% | -98.261% | -99.994% |
| Brainstorm Cell | 1.170% | -0.896% | -1.485% | -81.710% | 114.440% | -80.717% | - |
Comments
GlycoMimetics, Inc. (NASDAQ: GLYC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Show more
Ratings data for GLYC provided by MarketBeat
GlycoMimetics, Inc. (NASDAQ: GLYC) had its "overweight" rating re-affirmed by analysts at Capital One Financial Co..
Show more
Ratings data for GLYC provided by MarketBeat
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $12.00 price target on the stock.
Show more
Ratings data for GLYC provided by MarketBeat